Your browser doesn't support javascript.
loading
Effects of Compound Danshen Dripping Pills on Contrast-induced Nephropathy after Percutaneous Coronary Intervention and Patients ’Prognosis / 中国药房
China Pharmacy ; (12): 1880-1884, 2021.
Article in Chinese | WPRIM | ID: wpr-886283
ABSTRACT
OBJECTIVE:To observe the effects of Compound danshen drip ping pills on the prevention of contrast-induced nephropathy(CIN)after percutaneous coronary intervention (PCI)and its influence on clinical prognosis. METHODS :From Jan. to Jun. 2020,240 patients with coronary heart disease receiving PCI in Tianjin Chest Hospital were randomly divided into control group(120 cases)and Danshen dripping pills group (120 cases)according to random number table. The patients in both groups were injected with Lippaclitanol injection 1-5 mL slowly through radial or femoral artery sheath ,and intravenous hydration was performed before and after PCI ;Danshen dripping pills group was additionally given Compound danshen dripping pills 270 mg orally for a long term ,three times a day ,three days before and after PCI ,on the basis of the control group. The levels of renal function indexes [serum creatinine (Scr),blood urea nitrogenBUN),cystatin C (Cys-C),creatinine clearance rate (Ccr)], inflammatory reaction indexes [high sensitivity C-reactive proteinhs-CRP), interleukin-6IL-6)] and oxidative stress index [malondialdehyde (MDA)] were observed in 2 groups before and 72 hours after PCI. The occurrence of CIN in 2 groups was recorded 3 days after PCI therapy ;the occurrence of major cardiovascular adverse events was also observed during 1-year follow-up period. RESULTS :Before treatment ,there was no significant difference in serum renal function indexes ,inflammatory reaction indexes and oxidative stress index between 2 groups(P>0.05). Seventy-two hours after PCI ,serum levels of Scr ,BUN, Cys-C,hs-CRPIL-6 and MDA were increased significantly in 2 groups than before treatment ,while the Ccr were decreased significantly;those indexes of Danshen dripping pills group were significantly better than those of control group (P< 0.05). The incidence of CIN in Danshen dripping pills group was 4.2% after treatment , and total incidence of major cardiovascular adverse events was 13.3% during follow-up period,which were sign ificantly lower than 13.3% and 27.5% of control group (P<0.05). CONCLUSIONS :Compound danshen dripping pills may have a certain effect on the prevention of CIN in coronary heart disease patients after PCI ,and can reduce the incidence of major cardiovascular adverse events.

Full text: Available Index: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: China Pharmacy Year: 2021 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Prognostic study Language: Chinese Journal: China Pharmacy Year: 2021 Type: Article